SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-097586
Filing Date
2022-09-06
Accepted
2022-09-02 17:58:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2225125d1_defa14a.htm DEFA14A 15945
2 GRAPHIC tm2225125d1_defa14aimg001.jpg GRAPHIC 7703
3 GRAPHIC tm2225125d1_defa14aimg002.jpg GRAPHIC 2662
  Complete submission text file 0001104659-22-097586.txt   31711
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37350 | Film No.: 221226367
SIC: 3841 Surgical & Medical Instruments & Apparatus